SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-23-202936
Filing Date
2023-08-03
Accepted
2023-08-03 16:41:25
Documents
2
Group Members
VERSANT AFFILIATES FUND V, L.P.VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.VERSANT VANTAGE II GP, L.P.VERSANT VANTAGE II GP-GP, LLCVERSANT VANTAGE II, L.P.VERSANT VENTURE CAPITAL V (CANADA) LPVERSANT VENTURES V (CANADA), L.P.VERSANT VENTURES V GP-GP (CANADA

Document Format Files

Seq Description Document Type Size
1 SC 13D d515185dsc13d.htm SC 13D 208047
2 EX-99.1 d515185dex991.htm EX-99.1 13613
  Complete submission text file 0001193125-23-202936.txt   223638
Mailing Address ONE SANSOME STREET SUITE 1650 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 1650 SAN FRANCISCO CA 94104 650-233-7877
Versant Venture Capital V, L.P. (Filed by) CIK: 0001589097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010
Business Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010 347-897-5988
Turnstone Biologics Corp. (Subject) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94123 | Film No.: 231140827
SIC: 2836 Biological Products, (No Diagnostic Substances)